난임 치료와 선천성 기형 = Infertility Treatment and Congenital Malformations

다국어 초록 (Multilingual Abstract)

Over the past 30 years, fertility treatments including fertility enhancing drugs, artificial insemination and in vitro fertilization (IVF) have been revolutionized. Thus, worldwide, more than 5 million children have been born after assisted reproductive technology (ART) and domestically, it was announced that 2.83% of all births in 2011 were associated with financial support from the National Supporting Program for the Subfertile (NSPS) administered by the Korean Ministry of Health and Welfare (KMHW). As more women seek for fertility treatment, there is growing concern about the safety of the methods. In this review, we aim to summarize the literature on the association between fertility treatment and congenital malformations with respect to subfertility, fertility enhancing medications, and different ART methods. To sum up, although ARTs are associated with slight increase in some malformations, it appears that the increase in congenital malformations is due less to ART methods per se than to the biological perturbations that generated the infertility necessitated ART to achieve pregnancy. And no particular organ system seems disproportionately affected. It is often instructive to remind all couples attempting pregnancy that the baseline malformation rate is 2~3%, compared with 3~4% in ART.

참고문헌 (Reference)

1 Aboulghar H, "prospective controlled study of karyotyping for 430 consecutive babies conceived through intracytoplasmic sperm injection" 76 : 249-253, 2001

2 Croen LA, "Young maternal age and congenital malformations: a population-based study" 85 : 710-713, 1995

3 The Practice Committee of the American Society for Reproductive Medicine, "Use of clomiphene citrate in infertile women: a committee opinion" 100 : 341-348, 2013

4 Reefhuis J, "Use of clomiphene citrate and birth defects, National Birth Defects Prevention Study, 1997-2005" 26 : 451-457, 2011

5 Sørensen HT, "Use of clomifene during early pregnancy and risk of hypospadias: population based case-control study" 330 : 126-127, 2005

6 Biljan MM, "The outcome of 150 babies following the treatment with letrozole or letrozole and gonadotropins" 84 (84): S95-S231, 2005

7 Heisey AS, "Surveillance of congenital malformations in infants conceived through assisted reproductive technology or other fertility treatments" 103 (103): 119-126, 2015

8 Sagot P, "Similarly increased congenital anomaly rates after intrauterine insemination and IVF technologies: a retrospective cohort study" 27 : 902-909, 2012

9 Jwa J, "Risk of major congenital anomalies after assisted hatching: analysis of three-year data from the national assisted reproduction registry in Japan" 104 (104): 71-78, 2015

10 El-Chaar D, "Risk of birth defects increased in pregnancies conceived by assisted human reproduction" 92 (92): 1557-1561, 2009

11 Wikland M, "Obstetric outcomes after transfer of vitrified blastocysts" 25 : 1699-1707, 2010

12 Fedder J, "Neonatal outcome and congenital malformations in children born after ICSI with testicular or epididymal sperm: a controlled national cohort study" 28 (28): 230-240, 2013

13 Diamond MP, "NICHD Reproductive Medicine Network. Letrozole, Gonadotropin, or Clomiphene for Unexplained Infertility" 373 (373): 1230-1240, 2015

14 Pelkonen S, "Major congenital anomalies in children born after frozen embryo transfer: a cohort study 1995-2006" 29 : 1552-1557, 2014

15 Cox GF, "Intracytoplasmic sperm injection may increase the risk of imprinting defects" 71 : 162-164, 2002

16 Zhu JL, "Infertility, infertility treatment, and congenital malformations:Danish national birth cohort" 333 (333): 679-, 2006

17 Källén B, "In vitro fertilization (IVF) in Sweden: risk for congenital malformations after different IVF methods" 73 : 162-169, 2005

18 Lee GH, "Current status of assisted reproductive technology in Korea, 2011; Committee for Assisted Reproductive Technology, Statistics, Korean Society for Assisted Reproduction." 43 (43): 38-43, 2016

19 Källén B, "Congenital malformations in infants born after in vitro fertilization in Sweden" 88 (88): 137-143, 2010

20 Tulandi T, "Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate" 85 : 1761-1765, 2006

21 Seggers J, "Congenital anomalies in offspring of subfertile couples: a registry-based study in the northern Netherlands" 103 (103): 1001-1010, 2015

22 Pinborg A, "Congenital anomalies after assisted reproductive technology" 99 (99): 327-332, 2013

23 Greenland S, "Clomiphene citrate and neural tube defects: a pooled analysis of controlled epidemiologic studies and recommendations for future studies" 64 : 936-941, 1995

24 Meijer WM, "Clomiphene and hypospadias on a detailed level: signal or chance?" 76 (76): 249-252, 2006

25 Klemetti R, "Children born after assisted fertilization have an increased rate of major congenital anomalies" 84 : 1300-1307, 2005

26 Källén B, "Blastocyst versus cleavage stage transfer in in vitro fertilization: differences in neonatal outcome?" 94 : 1680-1683, 2010

27 Wen J1, "Birth defects in children conceived by in vitro fertilization and intracytoplasmic sperm injection:a meta-analysis" 97 : 1331-1337, 2012

28 Lie RT, "Birth defects in children conceived by ICSI compared with children conceived by other IVF-methods; a meta-analysis." 34 : 696-701, 2005

29 Simpson JL, "Birth defects and assisted reproductive technologies" 19 (19): 177-182, 2014

30 Vermeiden JP, "Are imprinting disorders more prevalent after human in vitro fertilization or intracytoplasmic sperm injection?" 99 (99): 642-651, 2013

31 Rimm AA, "A metaanalysis of the impact of IVF and ICSI on major malformations after adjusting for the effect of subfertility" 28 : 699-705, 2011